NMDARs (N-methyl-d-aspartate receptors) are considered to be a target for the inhibitory actions of ethanol. While profound inhibition of both native and recombinant NMDARs can be observed following the application of high concentrations of ethanol the levels of inhibition seen with lower concentrations of ethanol are more modest. Here, we report the effects of inhibiting NMDAR-mediated responses with ethanol concentrations that are experienced during the social consumption of alcohol comparing levels of inhibition seen with 'pure' ethanol with those produced by ethanol contained in three popular single malt whiskies.
Introduction
At the recent Biochemical Society Meeting 'Neuronal glutamate and GABA A receptor function in health and disease' held at St Andrews in July 2009, delegates were invited to a malt whisky tasting evening held in the magnificent surroundings of the University of St Andrews Bell Pettigrew Museum (http://biology.st-andrews. ac.uk/bellpet/index.aspx) and hosted by Vince Fusaro of Luvians Bottle Shop (Cupar). Given the topic of this Meeting this social event was extremely appropriate as both GABA A Rs (γ -aminobutyric acid type A receptors) and NMDARs (N-methyl-D-aspartate receptors) are probably the two ligand-gated ion channels most considered to be major sites of action for ethanol. Specifically GABA A Rs containing β3 and δ subunits are potentiated by ethanol [1, 2] , while NMDARs are inhibited by ethanol (reviewed in [3] [4] [5] ). Nevertheless many studies that examine the effects of ethanol on either GABA A Rs or NMDARs use concentrations of ethanol that would produce severe intoxication in most people ( 100 mM). Indeed the current 'drink-drive' limit in the US and UK is 80 mg of ethanol per 100 ml of blood [referred to as a BAC (blood alcohol content) of 0.08%] which, in terms of concentration, equals 17.36 mM ethanol. Recently, we published a study where we examined the effects of ethanol inhibition of recombinant GluN2A-and GluN2B-containing NMDARs using ethanol concentrations that would be experienced by individuals when consuming alcohol socially [6] . In this study, we showed that the level of inhibition of either GluN1/GluN2A or GluN1/GluN2B NMDARs was modest (<10% at 20 mM ethanol). As part of this study we also examined the effects of three single malt whiskies on the inhibition of NMDAR-mediated currents to determine whether if ethanol, when contained in an alcoholic beverage, displayed any differences in its inhibition of NMDARs. The results of these experiments are reported below. Three popular and readily available single malt whiskies (each 40% alcohol by volume) were chosen, which are referred to as Brand A, a 10-year-old Islay malt; Brand B, a 12-year-old Highland malt; and Brand C, a 10-year-old Speyside malt. These were purchased as 'miniatures' from a local specialist retailer (Royal Mile Whiskies, Edinburgh, U.K.). Experiments were performed using TEVC (twoelectrode voltage-clamp) recordings from Xenopus laevis oocytes expressing rat recombinant NMDARs containing either GluN1 and GluN2A or GluN1 and GluN2B subunits. Further details of methodologies can be found in previous publications (for example, see [6] [7] [8] [9] ).
Malt whiskies inhibit GluN1/GluN2A NMDAR-mediated responses to a lesser extent than pure ethanol
Before examining the effects of the three malt whiskies on NMDAR-mediated currents, we confirmed that none of our chosen brands possessed any intrinsic agonist activity. As can be seen from Figure 1 (A) TEVC current traces recorded from an oocyte expressing GluN1/GluN2A NMDARs none of the three whiskies (at an equivalent ethanol concentration of 80 mM) evoked significant responses. Indeed the level of currents produced by the whiskies at either GluN1/GluN2A or GluN1/GluN2B NMDARs was 1% of the current evoked by a saturating concentration of glutamate ( Figure 1B) . Thus, while each of these whiskies contain many more components (congeners) that will include higher alcohols, aldehydes, acids, esters and phenols in addition to ethanol, none appear to give rise to NMDARmediated currents, at least at the concentrations added in these experiments.
Four concentrations of ethanol (10, 20, 40 and 80 mM) were studied to assess its inhibitory action at recombinant NMDARs [6] . As illustrated in Figure 1 (C; grey symbols) Below these three traces is TEVC current recorded from the same oocyte when exposed to glutamate (+ glycine) to confirm that this oocyte expressed recombinant NMDARs. (B) Bar graph showing the extent to which each of the three whiskies (when applied at a concentration equivalent to 80 mM ethanol) evokes a change in the holding current (at -60 mV) in oocytes expressing GluN1/GluN2A (black bars; n = 9) or GluN1/GluN2B (grey bars; n = 6) NMDARs. (C) Mean percentage inhibition of GluN1/GluN2A NMDAR-mediated response, recorded at -60 mV, produced by malt whisky Brands A, B and C (n = 13, 12 and 15 respectively). Notice that the extent of the inhibition produced by each of the whiskies is less than that observed when ethanol (100%, grey symbols; data from [6] ) was used and that at an equivalent ethanol concentration of 10 mM, Brand B gives a small potentiation of the GluN1/GluN2A NMDAR-mediated currents. (D) Example TEVC current trace recorded from an oocyte expressing GluN1/GluN2A NMDARs. The potentiation of the current is clearly visible following the first application of Brand B whisky, while subsequent applications where the ethanol concentration is equivalent to 20, 40 or 80 mM show clear inhibition of the response. (E) Mean percentage inhibition of GluN1/GluN2B NMDAR-mediated response, recorded at -60 mV, produced by whisky Brands A, B and C (n = 14, 14 and 13 respectively). For each whisky, the levels of inhibition are not significantly different from those seen with ethanol (100%, grey symbols; data from [6] ). (F) Example TEVC current trace recorded from an oocyte expressing GluN1/GluN2B NMDARs. For this receptor combination, Brand B at all equivalent ethanol concentrations produces inhibition of the response.
GluN1/GluN2A NMDAR-mediated currents evoked by glutamate (100 μM at a holding potential of -60 mV) were inhibited by ethanol in a concentration-dependent manner with inhibition levels ranging from 6.4 ± 0.6% (n = 32; 10 mM ethanol) to 24.9 ± 1.3% (n = 32; 80 mM ethanol). The corresponding levels of inhibition of GluN1/GluN2B NMDAR-mediated responses are illustrated in Figure 1 (E; grey symbols) and ranged from 3.1 ± 0.5% (n = 21; 10 mM ethanol) to 27.1 ± 1.4% (n = 21; 80 mM ethanol). Figures 1(C)  and 1(D) illustrate the effects of the three whiskies on glutamate-evoked currents (at -60 mV) mediated by GluN1/GluN2A NMDARs. Equivalent data for GluN2B-containing NMDARs are shown in Figures 1(E) and 1(F) . For GluN2A-containing NMDARs, each of the three whiskies produced less inhibition that was observed when ethanol alone was applied. For example, at an equivalent ethanol concentration of 20 mM, each of the three whiskies produced nearly identical levels of inhibition (3.2 ± 1.0%, n = 13; 2.1 ± 0.7%, n = 12 and 3.6 ± 0.5%, n = 15 for Brands A, B and C respectively). These levels of inhibition are significantly less than those observed when ethanol alone is applied at the equivalent concentration (9.5 ± 0.8%). Intriguingly, Brand B (at an equivalent ethanol concentration of 10 mM) produced a small, but consistent, potentiation (mean = 4.5 ± 0.9%, range = 0-10.7%; n = 12) of GluN1/GluN2A NMDARmediated responses. This is clearly evident in the TEVC current trace illustrated in Figure 1(D) . Neither of the other two whiskies gave this effect.
For GluN1/GluN2B NMDARs, the levels of inhibition produced by each of the whiskies were similar to those obtained with ethanol alone. For example at an equivalent ethanol concentration of 20 mM, the inhibition levels seen with Brands A, B and C were 4.1 ± 0.9% (n = 14), 8.0 ± 0.9% (n = 14) and 4.7 ± 1.1% (n =13) respectively, compared with 6.5 ± 0.8% for ethanol alone ( Figure 1E ). Figure 1(F) shows a typical TEVC current trace recorded from an oocyte expressing GluN1/GluN2B NMDARs and illustrates the inhibition of the glutamate-evoked response by Brand B at each of the equivalent ethanol concentrations used in this study (10, 20 , 40 and 80 mM). For this NMDAR subtype there is no evidence of potentiation of the response at low ethanol concentrations.
Discussion and conclusions
To assess whether the effects of ethanol on NMDARmediated responses were different when ethanol was contained within an alcoholic beverage, we examined the effect of three malt whiskies on responses mediated by GluN2A-and GluN2B-containing NMDARs. For GluN1/GluN2B NMDARs, we obtained the same level of inhibition with each of the whiskies at equivalent ethanol concentration used in our earlier experiment with pure ethanol. For GluN1/GluN2A NMDARs, we obtained less inhibition. At the highest concentration tested, none of the whiskies displayed any endogenous agonist activity, ruling out the trivial explanation that the reduced levels of inhibition were simply a consequence of increased receptor activation.
For one whisky (Brand B), we observed potentiation of GluN1/GluN2A NMDAR-mediated responses at the lowest ethanol concentration applied. Potentiation of NMDAR function has been reported previously [10] at low concentrations of ethanol (<10 mM). Indeed in our experiments with 10 mM ethanol the range of inhibition measured (1.2-16.1%) might suggest that ethanol does have multiple actions at NMDARs and that the observed level of inhibition reflects the extent of both its inhibitory and potentiating actions. Thus, it might be the case that small potentiation seen with Brand B is a consequence of the presence of certain congeners in this whisky that mask ethanol's inhibitory actions, thus allowing an apparent potentiation to be observed. At higher ethanol concentrations, the main effect is, however, to cause inhibition of responses. We accept that metabolism of alcoholic beverages following oral ingestion will lead to the brain being exposed to a different complement of congeners than are contained within the samples applied directly to NMDARs and thus it is unwise to make any inference as to whether a potentiation of NMDAR-mediated responses would be observed in vivo following consumption of a single measure of Brand B.
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